Search

everythinglearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

A cream with a specific hormone blocker increases hair growth in mice.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

ALRN-6924 may prevent hair loss caused by chemotherapy.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Certain medications can help treat PCOS symptoms, but they aren't FDA-approved for this use.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.